Hereditary Transthyretin-Mediated Amyloid Polyneuropathy
Neurology·MeSH: Polyneuropathies
1 drug in development·1 company·1 clinical trial
Drug Pipeline by Phase
Phase 3(1)
| Drug | Company |
|---|---|
| eplontersen | IONIS PHARMACEUTICALS INC (IONS) |
Frequently asked questions
How many drugs are in development for Hereditary Transthyretin-Mediated Amyloid Polyneuropathy?
BioSniper tracks 1 drug in development for Hereditary Transthyretin-Mediated Amyloid Polyneuropathy across 1 company.
How many clinical trials target Hereditary Transthyretin-Mediated Amyloid Polyneuropathy?
There are 1 clinical trial targeting Hereditary Transthyretin-Mediated Amyloid Polyneuropathy tracked by BioSniper.
Deep-dive into Hereditary Transthyretin-Mediated Amyloid Polyneuropathy
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis